SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001999371-24-000976
Filing Date
2024-01-26
Accepted
2024-01-26 16:50:48
Documents
1
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9089
  Complete submission text file 0001999371-24-000976.txt   10644
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Oncology Inc. (Issuer) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRINCIPIA BIOPHARMA INC. 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address
Wolff Stefani (Reporting) CIK: 0001751790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40356 | Film No.: 24568626